Back to Search
KATIE MATTSON, PHARMD
PHARMD
Pharmacist
NPI: 1558984716Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
5262219-1701(UT)
Research & Publications (20)
Integrating human impacts and ecological integrity into a risk-based protocol for conservation planning.
PMID 17123003·Environ Manage·2007
8-other
An Escherichia coli aer mutant exhibits a reduced ability to colonize the streptomycin-treated mouse large intestine.
PMID 19130287·Antonie Van Leeuwenhoek·2009
7-preclinical
Comparison of a recombinant trypsin with the porcine pancreatic extract on sperm used for the in vitro production of bovine embryos.
PMID 18280563·Theriogenology·2008
4-observational
Successful artificial insemination in the corn snake, Elaphe gutatta, using fresh and cooled semen.
PMID 19360586·Zoo Biol·2007
8-other
Validation of an inductively coupled plasma mass spectrometry (ICP-MS) method for the determination of cerium, strontium, and titanium in ceramic materials used in radiological dispersal devices (RDDs).
PMID 17386806·Anal Chim Acta·2007
4-observational
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
PMID 16787687·Lung Cancer·2006
2-rct
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer.
PMID 16641904·Br J Cancer·2006
3-trial
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer.
PMID 16022920·Lung Cancer·2005
3-trial
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.
PMID 16022917·Lung Cancer·2005
3-trial
Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer.
PMID 15036884·Cancer Genet Cytogenet·2004
8-other
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer.
PMID 12871785·Lung Cancer·2003
3-trial
Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy.
PMID 12871780·Lung Cancer·2003
3-trial
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
PMID 12837811·J Clin Oncol·2003
3-trial
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.
PMID 12598353·Ann Oncol·2003
3-trial
Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study.
PMID 12488303·Ann Oncol·2003
3-trial
High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
PMID 12433733·Cancer Epidemiol Biomarkers Prev·2002
3-trial
DNA copy number changes in lung adenocarcinoma in younger patients.
PMID 11950910·Mod Pathol·2002
4-observational
Interferon trials in small cell lung cancer at one institution: a comparison of results obtained before and after initiation of systematic treatment trials using IFN-alpha in combination with other modalities.
PMID 11911799·J Interferon Cytokine Res·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 240 E WINCHESTER ST
MURRAY, UT 84107 - Phone
- (801) 262-5526
Quick Facts
- NPI
- 1558984716
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile